Biotechnology AIM Immunotech FDA Lifts Hold, Stock Surges 25%By MohamedMis2July 29, 2023 In a significant development, the FDA has recently lifted its hold on AIM Immunotech. Resulting in a remarkable 25% surge…
Biotechnology AIM ImmunoTech Promising Ovarian Cancer Trial ResultsBy MohamedMis2July 21, 2023 AIM ImmunoTech Inc. (AIM) has achieved a significant breakthrough in ovarian cancer treatment. As evidenced by the positive data from…
